Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11991669rdf:typepubmed:Citationlld:pubmed
pubmed-article:11991669lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:11991669lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:11991669lifeskim:mentionsumls-concept:C1155046lld:lifeskim
pubmed-article:11991669lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:11991669lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:11991669lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:11991669lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:11991669lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:11991669lifeskim:mentionsumls-concept:C0449450lld:lifeskim
pubmed-article:11991669pubmed:issue4lld:pubmed
pubmed-article:11991669pubmed:dateCreated2002-5-6lld:pubmed
pubmed-article:11991669pubmed:abstractTextFibroblasts are known to express histocompatibility leukocyte antigen DR (HLA-DR) molecules on their cell surface upon stimulation with interferon gamma (IFN- gamma), while the exact roles of HLA-DR on fibroblasts remain undetermined. To understand the role of HLA-DR molecules on fibroblasts, we examined whether: (1) fibroblasts act as antigen presenting cells (APC) which activate helper T (Th) cells; and/or (2) fibroblasts are activated via HLA-II molecules by making a T-cell receptor (TCR)-peptide-major histocompatibility complex (MHC) complex. We used Th(0) clone HT8.3, which recognizes an antigenic peptide (Ag53 p141-161) in the context of DRB1*1501, as well as IFN - gamma - treated and irradiated periodontal ligament fibroblasts (PDL) expressing DRB1*1501 molecules. When peptide-pulsed fibroblasts were co-incubated with HT8.3 treated by the protein synthesis inhibitor emetine, peptide-induced de novo expression of lymphokines and cell-surface molecules on T cells can be neglected. The antigen presenting capacity of these fibroblasts was evaluated by examining the proliferative responses of Th cells. Possible activation of fibroblasts by stimulation via HLA-DR molecules was evaluated by quantitating secreted cytokines in the supernatants after 18-h culture with or without anti-HLA-DR monoclonal antibody (mAb) or emetine-treated HT8.3. Indeed, Th cells did not show proliferative responses when peptide-pulsed PDL were used as APC, whereas PDL produced larger amounts of interleukin (IL) 6, IL-8, monocyte chemoattractant protein 1 (MCP-1) and regulated upon activation, normal T expressed and secreted (RANTES) compared with controls, when cultured with anti-HLA-DR mAb or emetine-treated HT8.3. These findings suggest that HLA-DR expressed on fibroblasts do not present antigens to induce T-cell proliferation, but may act as receptor molecules that transmit signals into fibroblasts, based on DR-peptide-TCR interaction, resulting in the secretion of several cytokine species.lld:pubmed
pubmed-article:11991669pubmed:languageenglld:pubmed
pubmed-article:11991669pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11991669pubmed:citationSubsetIMlld:pubmed
pubmed-article:11991669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11991669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11991669pubmed:statusMEDLINElld:pubmed
pubmed-article:11991669pubmed:monthFeblld:pubmed
pubmed-article:11991669pubmed:issn1043-4666lld:pubmed
pubmed-article:11991669pubmed:authorpubmed-author:MatsushitaSho...lld:pubmed
pubmed-article:11991669pubmed:authorpubmed-author:OhyamaHidekiHlld:pubmed
pubmed-article:11991669pubmed:authorpubmed-author:NishimuraFusa...lld:pubmed
pubmed-article:11991669pubmed:authorpubmed-author:MeguroMichioMlld:pubmed
pubmed-article:11991669pubmed:authorpubmed-author:TakashibaShog...lld:pubmed
pubmed-article:11991669pubmed:authorpubmed-author:MurayamaYojiYlld:pubmed
pubmed-article:11991669pubmed:copyrightInfoCopyright 2002 Elsevier Science Ltd. All rights reserved.lld:pubmed
pubmed-article:11991669pubmed:issnTypePrintlld:pubmed
pubmed-article:11991669pubmed:day21lld:pubmed
pubmed-article:11991669pubmed:volume17lld:pubmed
pubmed-article:11991669pubmed:ownerNLMlld:pubmed
pubmed-article:11991669pubmed:authorsCompleteYlld:pubmed
pubmed-article:11991669pubmed:pagination175-81lld:pubmed
pubmed-article:11991669pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11991669pubmed:meshHeadingpubmed-meshheading:11991669...lld:pubmed
pubmed-article:11991669pubmed:meshHeadingpubmed-meshheading:11991669...lld:pubmed
pubmed-article:11991669pubmed:meshHeadingpubmed-meshheading:11991669...lld:pubmed
pubmed-article:11991669pubmed:meshHeadingpubmed-meshheading:11991669...lld:pubmed
pubmed-article:11991669pubmed:meshHeadingpubmed-meshheading:11991669...lld:pubmed
pubmed-article:11991669pubmed:meshHeadingpubmed-meshheading:11991669...lld:pubmed
pubmed-article:11991669pubmed:meshHeadingpubmed-meshheading:11991669...lld:pubmed
pubmed-article:11991669pubmed:meshHeadingpubmed-meshheading:11991669...lld:pubmed
pubmed-article:11991669pubmed:meshHeadingpubmed-meshheading:11991669...lld:pubmed
pubmed-article:11991669pubmed:year2002lld:pubmed
pubmed-article:11991669pubmed:articleTitleCounter-antigen presentation: fibroblasts produce cytokines by signalling through HLA class II molecules without inducing T-cell proliferation.lld:pubmed
pubmed-article:11991669pubmed:affiliationDepartment of Pathophysiology/Periodontal Science, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama, 700-8525, Japan. imohyama@saitama-med.ac.jplld:pubmed
pubmed-article:11991669pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11991669pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11991669lld:pubmed